Literature DB >> 29400600

Cocaine abuse: Longitudinal MR imaging of lasting diffused leukoencephalopathy.

Shuo Li1, Roni Manyevitch2, Kaltrina Sedaliu3, Ahmed Abdelbaki1, Nishant Gupta4, Anil Kumar5, Yogesh Kumar6, Mark Rosovsky1.   

Abstract

Cocaine use has been known to cause a number of adverse neurological conditions, such as cerebral ischemia and posterior reversible leukoencephalopathy. The radiologic appearance of cocaine-induced leukoencephalopathy is confounded by a common contaminant, levamisole, which is also known to cause multifocal leukoencephalopathy. However, we encountered a case of diffuse leukoencephalopathy in a patient with cocaine use that had extensive involvement of the cerebral white matter, globus pallidi as well as the cerebellum. Our case also presented with a severe clinical presentation, with the patient demonstrating minimal neurologic response after a prolonged period of critical care management. The severe clinical course and diffuse radiologic involvement of our case differs from previously reported cases of cocaine- or levamisole-induced leukoencephalopathy.

Entities:  

Keywords:  Leukoencephalopathy; MRI; cocaine abuse; levamisole

Mesh:

Year:  2018        PMID: 29400600      PMCID: PMC5882067          DOI: 10.1177/1971400918757090

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  9 in total

Review 1.  Toxic leukoencephalopathy.

Authors:  C M Filley; B K Kleinschmidt-DeMasters
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

2.  Multifocal inflammatory leukoencephalopathy associated with cocaine abuse: is levamisole responsible?

Authors:  Paul D Blanc; Cynthia Chin; Kara L Lynch
Journal:  Clin Toxicol (Phila)       Date:  2012-06-18       Impact factor: 4.467

3.  Your brain on drugs: imaging of drug-related changes in the central nervous system.

Authors:  Benita Tamrazi; Jeevak Almast
Journal:  Radiographics       Date:  2012 May-Jun       Impact factor: 5.333

4.  Levamisole-induced multifocal inflammatory leukoencephalopathy: clinical characteristics, outcome, and impact of treatment in 31 patients.

Authors:  Vin-Cent Wu; Jenq-Wen Huang; Huang-Chun Lien; Sung-Tsang Hsieh; Hon-Man Liu; Chih-Chao Yang; Yen-Hung Lin; Juey-Jen Hwang; Kwan-Dun Wu
Journal:  Medicine (Baltimore)       Date:  2006-07       Impact factor: 1.889

Review 5.  Toxic leukoencephalopathy.

Authors:  C M Filley
Journal:  Clin Neuropharmacol       Date:  1999 Sep-Oct       Impact factor: 1.592

6.  Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients.

Authors:  Ning'an Xu; Wenbin Zhou; Shuyu Li; Gaofeng Zhou; Ning Zhang; Jinghui Liang
Journal:  J Neuroimaging       Date:  2009-01-29       Impact factor: 2.486

7.  Cocaine-induced recurrent leukoencephalopathy.

Authors:  Alejandra González-Duarte; Ricardo Williams
Journal:  Neuroradiol J       Date:  2013-11-07

8.  Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging.

Authors:  Alexander M McKinney; Stephen A Kieffer; Rogerich T Paylor; Karen S SantaCruz; Ayse Kendi; Leandro Lucato
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

Review 9.  Toxins in Brain! Magnetic Resonance (MR) Imaging of Toxic Leukoencephalopathy - A Pictorial Essay.

Authors:  Yogesh Kumar; Douglas Drumsta; Manisha Mangla; Nishant Gupta; Kusum Hooda; Jeevak Almast; Rajiv Mangla
Journal:  Pol J Radiol       Date:  2017-06-13
  9 in total
  1 in total

1.  Full Recovery From Cocaine-Induced Toxic Leukoencephalopathy: Emphasizing the Role of Neuroinflammation and Brain Edema.

Authors:  Edward C Mader; Alexander B Ramos; Roberto A Cruz; Lionel A Branch
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.